Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, T-Cell, Cutaneous × Everolimus × Clear all

Phase

Phase 1/2 3 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Breast Neoplasms 44 Carcinoma, Renal Cell 25 Neoplasm Metastasis 15 Neoplasms 13 Kidney Neoplasms 11 Neuroendocrine Tumors 10 Carcinoma, Neuroendocrine 9 Prostatic Neoplasms 7 Thyroid Neoplasms 6 Sarcoma 6 Meningioma 6 Melanoma 6 Lymphoma 6 Tuberous Sclerosis 5 Recurrence 5 Lymphoma, Mantle-Cell 5 Head and Neck Neoplasms 5 Endometrial Neoplasms 5 Carcinoma 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Glioma 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Astrocytoma 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Neurofibromatosis 2 3

Interventions

fludarabine phosphate 17 Mycophenolic Acid 16 Cyclophosphamide 16 Tacrolimus 15 Peripheral Blood Stem Cell Transplantation 15 Antilymphocyte Serum 13 Whole-Body Irradiation 11 Busulfan 11 Cyclosporine 10 Methotrexate 8 Melphalan 7 Bexarotene 6 Sirolimus 5 Radiotherapy 5 Methylprednisolone 5 Flow Cytometry 5 Filgrastim 5 pembrolizumab 4 mogamulizumab 4 Vorinostat 4 Therapeutics 4 Rituximab 4 Lenalidomide 4 Etoposide 4 Brentuximab Vedotin 4 Alemtuzumab 4 thymoglobulin 3 sargramostim 3 romidepsin 3 Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01637090 2017-01-12

CTCL

Boston Medical Center

Phase 2 Terminated

3 enrolled 6 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡